Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iovance Biotherapeutics (IOVA) Other Non-Current Liabilities (2018 - 2019)

Iovance Biotherapeutics (IOVA) has disclosed Other Non-Current Liabilities for 4 consecutive years, with $53000.0 as the latest value for Q3 2019.

  • On a quarterly basis, Other Non-Current Liabilities changed N/A to $53000.0 in Q3 2019 year-over-year; TTM through Sep 2019 was $53000.0, a N/A change, with the full-year FY2018 number at $230000.0, changed N/A from a year prior.
  • Other Non-Current Liabilities was $53000.0 for Q3 2019 at Iovance Biotherapeutics, roughly flat from $53000.0 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $230000.0 in Q4 2018 to a low of $53000.0 in Q1 2019.